US Stock MarketDetailed Quotes

BRNS Barinthus Biotherapeutics

Watchlist
  • 0.895
  • -0.094-9.47%
Close Nov 22 16:00 ET
  • 0.900
  • +0.005+0.59%
Post 16:44 ET
35.99MMarket Cap-600P/E (TTM)

Barinthus Biotherapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Total revenue
14.97M
0
0
-98.21%802K
0
0
-98.04%334K
-96.88%468K
16,580.22%44.7M
645,800.00%6.46M
Operating revenue
--14.97M
--0
--0
-98.21%802K
--0
--0
-98.04%334K
-96.88%468K
16,580.22%44.7M
645,800.00%6.46M
Cost of revenue
Gross profit
Operating expense
59.34%23.74M
-32.62%17.59M
-21.52%16.32M
71.05%81.26M
-38.18%19.45M
4,393.95%14.9M
769.82%26.11M
56.17%20.8M
14.50%47.5M
103.56%31.46M
Selling and administrative expenses
1,296.46%13.42M
-45.15%7.2M
-50.62%5.99M
523.12%39.84M
-29.69%13.62M
108.89%961K
--13.13M
231.37%12.14M
-74.54%6.39M
97.88%19.37M
-General and administrative expense
1,296.46%13.42M
-45.15%7.2M
-50.62%5.99M
523.12%39.84M
-29.69%13.62M
108.89%961K
--13.13M
231.37%12.14M
-74.54%6.39M
97.88%19.37M
Research and development costs
-24.45%10.53M
-15.52%10.97M
21.65%10.53M
0.74%41.41M
-51.77%5.83M
33.16%13.94M
45.99%12.98M
-10.32%8.66M
151.13%41.11M
113.35%12.1M
Other operating expenses
---210K
---577K
---205K
----
----
----
----
----
----
----
Operating profit
41.13%-8.77M
31.75%-17.59M
19.71%-16.32M
-2,772.30%-80.45M
22.22%-19.45M
-328.81%-14.9M
-283.33%-25.78M
-1,294.30%-20.33M
93.20%-2.8M
-61.77%-25M
Net non-operating interest income expense
224.87%614K
22.64%623K
-51.95%763K
-7.62%2.85M
-56.78%564K
-81.74%189K
-23.26%508K
17,544.44%1.59M
215.68%3.08M
7,350.00%1.31M
Non-operating interest income
221.94%631K
21.65%635K
-51.20%775K
-7.28%2.88M
-56.87%571K
-81.06%196K
-21.97%522K
1,813.25%1.59M
155,050.00%3.1M
--1.32M
Non-operating interest expense
142.86%17K
-14.29%12K
--12K
47.37%28K
--7K
--7K
100.00%14K
--0
-99.29%19K
----
Other net income (expense)
1,400.00%26K
-93.55%20K
90.83%1.08M
50.00%774K
-2K
507.84%310K
107.82%567K
54.03%516K
Other non- operating income (expenses)
1,400.00%26K
-93.55%20K
----
90.83%1.08M
50.00%774K
---2K
507.84%310K
----
70.78%567K
54.03%516K
Income before tax
44.73%-8.13M
32.09%-16.95M
16.98%-15.56M
-9,102.59%-76.52M
21.88%-18.11M
-294.95%-14.71M
-268.95%-24.96M
-1,195.21%-18.74M
101.66%850K
-53.13%-23.18M
Income tax
99.50%-3K
99.38%-7K
92.83%-37K
31.22%-3.08M
59.39%-820K
10.53%-603K
-24.15%-1.14M
40.21%-516K
-15,867.86%-4.47M
-6,409.38%-2.02M
Net income
42.39%-8.13M
28.88%-16.94M
14.83%-15.52M
-1,480.32%-73.45M
18.30%-17.29M
-271.63%-14.11M
-251.85%-23.82M
-807.96%-18.22M
110.41%5.32M
-39.50%-21.16M
Net income continuous Operations
42.39%-8.13M
28.88%-16.94M
14.83%-15.52M
-1,480.32%-73.45M
18.30%-17.29M
-271.63%-14.11M
-251.85%-23.82M
-807.96%-18.22M
110.41%5.32M
-39.50%-21.16M
Minority interest income
60.53%-15K
45.45%-12K
27.91%-31K
-376.19%-100K
-88.46%3K
-80.95%-38K
-450.00%-22K
-95.45%-43K
91.50%-21K
144.83%26K
Net income attributable to the parent company
42.34%-8.11M
28.87%-16.93M
14.80%-15.49M
-1,473.03%-73.35M
18.39%-17.29M
-270.74%-14.07M
-251.67%-23.8M
-800.31%-18.18M
110.50%5.34M
-40.20%-21.19M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
42.34%-8.11M
28.87%-16.93M
14.80%-15.49M
-1,473.03%-73.35M
18.39%-17.29M
-270.74%-14.07M
-251.67%-23.8M
-800.31%-18.18M
110.50%5.34M
-40.20%-21.19M
Basic earnings per share
43.24%-0.21
30.65%-0.43
16.67%-0.4
-1,464.29%-1.91
21.05%-0.45
-268.18%-0.37
-247.62%-0.62
-785.71%-0.48
107.14%0.14
-50.00%-0.57
Diluted earnings per share
43.24%-0.21
30.65%-0.43
16.67%-0.4
-1,464.29%-1.91
21.05%-0.45
-268.18%-0.37
-251.22%-0.62
-805.88%-0.48
107.14%0.14
-50.00%-0.57
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Total revenue 14.97M00-98.21%802K00-98.04%334K-96.88%468K16,580.22%44.7M645,800.00%6.46M
Operating revenue --14.97M--0--0-98.21%802K--0--0-98.04%334K-96.88%468K16,580.22%44.7M645,800.00%6.46M
Cost of revenue
Gross profit
Operating expense 59.34%23.74M-32.62%17.59M-21.52%16.32M71.05%81.26M-38.18%19.45M4,393.95%14.9M769.82%26.11M56.17%20.8M14.50%47.5M103.56%31.46M
Selling and administrative expenses 1,296.46%13.42M-45.15%7.2M-50.62%5.99M523.12%39.84M-29.69%13.62M108.89%961K--13.13M231.37%12.14M-74.54%6.39M97.88%19.37M
-General and administrative expense 1,296.46%13.42M-45.15%7.2M-50.62%5.99M523.12%39.84M-29.69%13.62M108.89%961K--13.13M231.37%12.14M-74.54%6.39M97.88%19.37M
Research and development costs -24.45%10.53M-15.52%10.97M21.65%10.53M0.74%41.41M-51.77%5.83M33.16%13.94M45.99%12.98M-10.32%8.66M151.13%41.11M113.35%12.1M
Other operating expenses ---210K---577K---205K----------------------------
Operating profit 41.13%-8.77M31.75%-17.59M19.71%-16.32M-2,772.30%-80.45M22.22%-19.45M-328.81%-14.9M-283.33%-25.78M-1,294.30%-20.33M93.20%-2.8M-61.77%-25M
Net non-operating interest income expense 224.87%614K22.64%623K-51.95%763K-7.62%2.85M-56.78%564K-81.74%189K-23.26%508K17,544.44%1.59M215.68%3.08M7,350.00%1.31M
Non-operating interest income 221.94%631K21.65%635K-51.20%775K-7.28%2.88M-56.87%571K-81.06%196K-21.97%522K1,813.25%1.59M155,050.00%3.1M--1.32M
Non-operating interest expense 142.86%17K-14.29%12K--12K47.37%28K--7K--7K100.00%14K--0-99.29%19K----
Other net income (expense) 1,400.00%26K-93.55%20K90.83%1.08M50.00%774K-2K507.84%310K107.82%567K54.03%516K
Other non- operating income (expenses) 1,400.00%26K-93.55%20K----90.83%1.08M50.00%774K---2K507.84%310K----70.78%567K54.03%516K
Income before tax 44.73%-8.13M32.09%-16.95M16.98%-15.56M-9,102.59%-76.52M21.88%-18.11M-294.95%-14.71M-268.95%-24.96M-1,195.21%-18.74M101.66%850K-53.13%-23.18M
Income tax 99.50%-3K99.38%-7K92.83%-37K31.22%-3.08M59.39%-820K10.53%-603K-24.15%-1.14M40.21%-516K-15,867.86%-4.47M-6,409.38%-2.02M
Net income 42.39%-8.13M28.88%-16.94M14.83%-15.52M-1,480.32%-73.45M18.30%-17.29M-271.63%-14.11M-251.85%-23.82M-807.96%-18.22M110.41%5.32M-39.50%-21.16M
Net income continuous Operations 42.39%-8.13M28.88%-16.94M14.83%-15.52M-1,480.32%-73.45M18.30%-17.29M-271.63%-14.11M-251.85%-23.82M-807.96%-18.22M110.41%5.32M-39.50%-21.16M
Minority interest income 60.53%-15K45.45%-12K27.91%-31K-376.19%-100K-88.46%3K-80.95%-38K-450.00%-22K-95.45%-43K91.50%-21K144.83%26K
Net income attributable to the parent company 42.34%-8.11M28.87%-16.93M14.80%-15.49M-1,473.03%-73.35M18.39%-17.29M-270.74%-14.07M-251.67%-23.8M-800.31%-18.18M110.50%5.34M-40.20%-21.19M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 42.34%-8.11M28.87%-16.93M14.80%-15.49M-1,473.03%-73.35M18.39%-17.29M-270.74%-14.07M-251.67%-23.8M-800.31%-18.18M110.50%5.34M-40.20%-21.19M
Basic earnings per share 43.24%-0.2130.65%-0.4316.67%-0.4-1,464.29%-1.9121.05%-0.45-268.18%-0.37-247.62%-0.62-785.71%-0.48107.14%0.14-50.00%-0.57
Diluted earnings per share 43.24%-0.2130.65%-0.4316.67%-0.4-1,464.29%-1.9121.05%-0.45-268.18%-0.37-251.22%-0.62-805.88%-0.48107.14%0.14-50.00%-0.57
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data